Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL7159319 | 1.00 | CA5A (0.75) | — | |
| Sulfuric Acid SCHEMBL28664499 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL28470671 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL28466915 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL2233694 | 0.94 | CA5A (0.67) | — | |
| Sulfuric Acid SCHEMBL23199870 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL28330297 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL6000160 | 0.94 | CA5A (0.67) | — | |
| Sulfuric Acid SCHEMBL21487552 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL11760918 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109851600-A | The preparation method of benzofuran -2- (3H) -one | 上海凡生化学科技有限公司 | 2019-06-07 | — | — | CN | claimed |
| US-20080160084-A1 | Natural Water-Insoluble Encapsulation Compositions and Processes for Preparing Same | COLAROME, INC. (CA) | 2008-07-03 | — | — | US | claimed |
| EP-0305965-B1 | PROCESS FOR PREPARING ESTERS OF UNSATURATED ALCOHOLS | UNION CARBIDE CORPORATION (US) | 1992-09-02 | — | — | EP | claimed |
| EP-0305965-A1 | Process for preparing esters of unsaturated alcohols | UNION CARBIDE CORPORATION (US) | 1989-03-08 | — | — | EP | claimed |
| US-12239643-B2 | Therapeutic agent for inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2025-03-04 | — | — | US | disclosed |
| CN-112167466-B | Orange-flavor Australian freshwater lobster culture feed and processing technology thereof | 广东东腾饲料有限公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-115947352-A | Method for extracting lithium from lepidolite by using fluidized bed | 河南鹏辉循环科技有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-113957088-A | Artificial design and application of intercellular communication system | 中国科学院微生物研究所 | 2022-01-21 | — | — | CN | disclosed |
| US-20210315892-A1 | THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
| EP-3560925-B1 | NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF | MEIJI SEIKA PHARMA CO LTD (JP) | 2021-06-02 | — | — | EP | disclosed |
| EP-3815687-A1 | THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES | Meiji Seika Pharma Co., Ltd. (JP) | 2021-05-05 | — | — | EP | disclosed |
| US-10669283-B2 | Compound and pharmacologically acceptable salt thereof | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2020-06-02 | — | — | US | disclosed |
| EP-3560925-A1 | NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF | Meiji Seika Pharma Co., Ltd. (JP) | 2019-10-30 | — | — | EP | disclosed |
| US-20190322686-A1 | NOVEL COMPOUND AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2019-10-24 | — | — | US | disclosed |
| CN-105585361-A | Selenium-enriched mushroom grass culture medium and method for producing selenium-enriched shiitake mushrooms | JINGGANGSHAN JINGXIANG JUNCAO ECOLOGICAL TECH CO LTD | 2016-05-18 | — | — | CN | disclosed |
| CN-101705380-B | Method for recovering rare earth from rare earth-containing aluminum-silicon materials | GRIREM ADVANCED MAT CO LTD | 2013-10-23 | — | — | CN | disclosed |
| CN-101705380-A | Method for recovering rare earth from rare earth-containing aluminum-silicon materials | BEIJING NONFERROUS METAL | 2010-05-12 | — | — | CN | disclosed |